Lmo4 Deficiency Enhances Susceptibility to Cisplatin-Induced Cochlear Apoptosis and Hearing Loss.
Adaptor Proteins, Signal Transducing
/ genetics
Animals
Apoptosis
/ drug effects
Cisplatin
/ adverse effects
Cochlea
/ pathology
Evoked Potentials, Auditory, Brain Stem
/ drug effects
Genetic Predisposition to Disease
Hearing Loss
/ chemically induced
LIM Domain Proteins
/ genetics
Mice
Mice, Knockout
Cisplatin
Cochlea
Hearing loss
LMO4
Ototoxicity
STAT3
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
18
06
2020
accepted:
24
11
2020
pubmed:
8
1
2021
medline:
20
11
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
Cisplatin, a potent chemotherapeutic drug, induces ototoxicity, which limits its clinical utility. Cisplatin-induced oxidative stress plays a causal role in cochlear apoptosis while the consequent nitrative stress leads to the nitration of LIM domain only 4 (LMO4), a transcriptional regulator, and decreases its cochlear expression levels. Here, we show a direct link between cochlear LMO4 and cisplatin-induced hearing loss by employing a Lmo4 conditional knockout mouse model (Lmo4
Identifiants
pubmed: 33411315
doi: 10.1007/s12035-020-02226-4
pii: 10.1007/s12035-020-02226-4
pmc: PMC8026651
mid: NIHMS1661194
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
LIM Domain Proteins
0
Lmo4 protein, mouse
0
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2019-2029Subventions
Organisme : NIEHS NIH HHS
ID : K01 ES028750
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES020957
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC016835
Pays : United States
Organisme : Wayne State University
ID : Faculty Start-up
Références
Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC et al (2014) Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics. J Natl Cancer Inst 106(5):dju044. https://doi.org/10.1093/jnci/dju044
doi: 10.1093/jnci/dju044
pubmed: 24623533
pmcid: 4568989
Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L et al (2017) Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun 8(1):1654. https://doi.org/10.1038/s41467-017-01837-1
doi: 10.1038/s41467-017-01837-1
pubmed: 29162831
pmcid: 5698400
Brock PR, Knight KR, Freyer DR, Campbell KC, Steyger PS, Blakley BW, Rassekh SR, Chang KW et al (2012) Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 30(19):2408–2417. https://doi.org/10.1200/JCO.2011.39.1110
doi: 10.1200/JCO.2011.39.1110
pubmed: 22547603
pmcid: 3675696
Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 34(8):458–469. https://doi.org/10.1016/j.tips.2013.05.006
doi: 10.1016/j.tips.2013.05.006
pubmed: 23769626
Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226(1–2):157–167. https://doi.org/10.1016/j.heares.2006.09.015
doi: 10.1016/j.heares.2006.09.015
pubmed: 17113254
Ruhl D, Du TT, Wagner EL, Choi JH, Li S, Reed R, Kim K, Freeman M et al (2019) Necroptosis and apoptosis contribute to cisplatin and aminoglycoside ototoxicity. J Neurosci 39(15):2951–2964. https://doi.org/10.1523/JNEUROSCI.1384-18.2019
doi: 10.1523/JNEUROSCI.1384-18.2019
pubmed: 30733218
pmcid: 6462451
Jamesdaniel S (2014) Downstream targets of Lmo4 are modulated by cisplatin in the inner ear of Wistar rats. PLoS One 9(12):e115263. https://doi.org/10.1371/journal.pone.0115263
doi: 10.1371/journal.pone.0115263
pubmed: 25501662
pmcid: 4264883
Jamesdaniel S, Coling D, Hinduja S, Ding D, Li J, Cassidy L, Seigel GM, Qu J et al (2012) Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4. J Biol Chem 287(22):18674–18686. https://doi.org/10.1074/jbc.M111.297960
doi: 10.1074/jbc.M111.297960
pubmed: 22493493
pmcid: 3365719
Rosati R, Shahab M, Neumann WL, Jamesdaniel S (2019) Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells. Exp Cell Res 381(1):105–111. https://doi.org/10.1016/j.yexcr.2019.05.008
doi: 10.1016/j.yexcr.2019.05.008
pubmed: 31078568
pmcid: 6546436
Rathinam R, Ghosh S, Neumann WL, Jamesdaniel S (2015) Cisplatin-induced apoptosis in auditory, renal, and neuronal cells is associated with nitration and downregulation of LMO4. Cell Death Discov 1. https://doi.org/10.1038/cddiscovery.2015.52
Deng M, Luo XJ, Pan L, Yang H, Xie X, Liang G, Huang L, Hu F et al (2014) LMO4 functions as a negative regulator of sensory organ formation in the mammalian cochlea. J Neurosci 34(30):10072–10077. https://doi.org/10.1523/JNEUROSCI.0352-14.2014
doi: 10.1523/JNEUROSCI.0352-14.2014
pubmed: 25057208
pmcid: 4107398
Chen HH, Schock SC, Xu J, Safarpour F, Thompson CS, Stewart AF (2007) Extracellular ATP-dependent upregulation of the transcription cofactor LMO4 promotes neuron survival from hypoxia. Exp Cell Res 313(14):3106–3116. https://doi.org/10.1016/j.yexcr.2007.04.026
doi: 10.1016/j.yexcr.2007.04.026
pubmed: 17524392
Tian Y, Wang N, Lu Z (2010) Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells. Clin Exp Metastasis 27(7):455–463. https://doi.org/10.1007/s10585-010-9332-1
doi: 10.1007/s10585-010-9332-1
pubmed: 20526802
Jamesdaniel S, Rathinam R, Neumann WL (2016) Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity. Redox Biol 10:257–265. https://doi.org/10.1016/j.redox.2016.10.016
doi: 10.1016/j.redox.2016.10.016
pubmed: 27821327
pmcid: 5099269
Rathinam R, Rosati R, Jamesdaniel S (2018) CRISPR/Cas9-mediated knockout of Lim-domain only four retards organ of Corti cell growth. J Cell Biochem 119(4):3545–3553. https://doi.org/10.1002/jcb.26529
doi: 10.1002/jcb.26529
pubmed: 29143984
pmcid: 6366322
Novotny-Diermayr V, Lin B, Gu L, Cao X (2005) Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction. J Biol Chem 280(13):12747–12757. https://doi.org/10.1074/jbc.M500175200
doi: 10.1074/jbc.M500175200
pubmed: 15677447
Schock SC, Xu J, Duquette PM, Qin Z, Lewandowski AJ, Rai PS, Thompson CS, Seifert EL et al (2008) Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-gamma requires a novel essential cofactor LMO4. J Neurosci 28(47):12433–12444. https://doi.org/10.1523/JNEUROSCI.2897-08.2008
doi: 10.1523/JNEUROSCI.2897-08.2008
pubmed: 19020036
pmcid: 2954187
Setogawa T, Shinozaki-Yabana S, Masuda T, Matsuura K, Akiyama T (2006) The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1. Biochem Biophys Res Commun 343(4):1186–1190. https://doi.org/10.1016/j.bbrc.2006.03.077
doi: 10.1016/j.bbrc.2006.03.077
pubmed: 16580634
Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X, Yu Z, Gill GN et al (2007) The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 26(44):6431–6441. https://doi.org/10.1038/sj.onc.1210465
doi: 10.1038/sj.onc.1210465
pubmed: 17452977
Levano S, Bodmer D (2015) Loss of STAT1 protects hair cells from ototoxicity through modulation of STAT3, c-Jun, Akt, and autophagy factors. Cell Death Dis 6:e2019. https://doi.org/10.1038/cddis.2015.362
doi: 10.1038/cddis.2015.362
pubmed: 26673664
pmcid: 4720895
Schmitt NC, Rubel EW, Nathanson NM (2009) Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate. J Neurosci 29(12):3843–3851. https://doi.org/10.1523/JNEUROSCI.5842-08.2009
doi: 10.1523/JNEUROSCI.5842-08.2009
pubmed: 19321781
pmcid: 2707781
Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V (2011) Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis 2:e180. https://doi.org/10.1038/cddis.2011.63
doi: 10.1038/cddis.2011.63
pubmed: 21776018
pmcid: 3199718
Stephanou A, Latchman DS (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23(3):177–182. https://doi.org/10.1080/08977190500178745
doi: 10.1080/08977190500178745
pubmed: 16243709
Hu X, Ivashkiv LB (2009) Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 31(4):539–550. https://doi.org/10.1016/j.immuni.2009.09.002
doi: 10.1016/j.immuni.2009.09.002
pubmed: 19833085
pmcid: 2774226
Deng M, Pan L, Xie X, Gan L (2010) Requirement for Lmo4 in the vestibular morphogenesis of mouse inner ear. Dev Biol 338(1):38–49. https://doi.org/10.1016/j.ydbio.2009.11.003
doi: 10.1016/j.ydbio.2009.11.003
pubmed: 19913004
Hughes AL, Hussain N, Pafford R, Parham K (2014) Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model. Otolaryngol Head Neck Surg 150(1):115–120. https://doi.org/10.1177/0194599813511948
doi: 10.1177/0194599813511948
pubmed: 24233060
Berndtsson M, Hagg M, Panaretakis T, Havelka AM, Shoshan MC, Linder S (2007) Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer 120(1):175–180. https://doi.org/10.1002/ijc.22132
doi: 10.1002/ijc.22132
pubmed: 17044026
More SS, Akil O, Ianculescu AG, Geier EG, Lustig LR, Giacomini KM (2010) Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci 30(28):9500–9509. https://doi.org/10.1523/JNEUROSCI.1544-10.2010
doi: 10.1523/JNEUROSCI.1544-10.2010
pubmed: 20631178
pmcid: 2949060
Thomas AJ, Hailey DW, Stawicki TM, Wu P, Coffin AB, Rubel EW, Raible DW, Simon JA et al (2013) Functional mechanotransduction is required for cisplatin-induced hair cell death in the zebrafish lateral line. J Neurosci 33(10):4405–4414. https://doi.org/10.1523/JNEUROSCI.3940-12.2013
doi: 10.1523/JNEUROSCI.3940-12.2013
pubmed: 23467357
pmcid: 3666553
Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D et al (2016) Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3/STAT1 inflammatory pathway in the cochlea. J Neurosci 36(14):3962–3977. https://doi.org/10.1523/JNEUROSCI.3111-15.2016
doi: 10.1523/JNEUROSCI.3111-15.2016
pubmed: 27053204
pmcid: 4821909
Park HJ, Kim MJ, Rothenberger C, Kumar A, Sampson EM, Ding D, Han C, White K et al (2019) GSTA4 mediates reduction of cisplatin ototoxicity in female mice. Nat Commun 10(1):4150. https://doi.org/10.1038/s41467-019-12073-0
doi: 10.1038/s41467-019-12073-0
pubmed: 31515474
pmcid: 6742643
Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH (2004) NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279(44):46065–46072. https://doi.org/10.1074/jbc.M403046200
doi: 10.1074/jbc.M403046200
pubmed: 15326186
Li G, Liu W, Frenz D (2006) Cisplatin ototoxicity to the rat inner ear: A role for HMG1 and iNOS. Neurotoxicology 27(1):22–30. https://doi.org/10.1016/j.neuro.2005.05.010
doi: 10.1016/j.neuro.2005.05.010
pubmed: 16125245
Watanabe K, Inai S, Jinnouchi K, Bada S, Hess A, Michel O, Yagi T (2002) Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res 22(6C):4081–4085
pubmed: 12553036
Jamesdaniel S, Ding D, Kermany MH, Davidson BA, Knight PR 3rd, Salvi R, Coling DE (2008) Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity. J Proteome Res 7(8):3516–3524. https://doi.org/10.1021/pr8002479
doi: 10.1021/pr8002479
pubmed: 18578524
pmcid: 2570323
Low IC, Loh T, Huang Y, Virshup DM, Pervaiz S (2014) Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56delta stabilizes its antiapoptotic activity. Blood 124(14):2223–2234. https://doi.org/10.1182/blood-2014-03-563296
doi: 10.1182/blood-2014-03-563296
pubmed: 25082878
Joshi MS, Mihm MJ, Cook AC, Schanbacher BL, Bauer JA (2015) Alterations in connexin 43 during diabetic cardiomyopathy: Competition of tyrosine nitration versus phosphorylation. J Diabetes 7(2):250–259. https://doi.org/10.1111/1753-0407.12164
doi: 10.1111/1753-0407.12164
pubmed: 24796789
Franco MC, Ye Y, Refakis CA, Feldman JL, Stokes AL, Basso M, Melero Fernandez de Mera RM, Sparrow NA et al (2013) Nitration of Hsp90 induces cell death. Proc Natl Acad Sci U S A 110(12):E1102–E1111. https://doi.org/10.1073/pnas.1215177110
doi: 10.1073/pnas.1215177110
pubmed: 23487751
pmcid: 3607042
Venkatesan A, Uzasci L, Chen Z, Rajbhandari L, Anderson C, Lee MH, Bianchet MA, Cotter R et al (2011) Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: Role for nitrotyrosination. Mol Brain 4:28. https://doi.org/10.1186/1756-6606-4-28
doi: 10.1186/1756-6606-4-28
pubmed: 21708025
pmcid: 3142219
Curry-McCoy TV, Osna NA, Donohue TM Jr (2009) Modulation of lysozyme function and degradation after nitration with peroxynitrite. Biochim Biophys Acta 1790(8):778–786. https://doi.org/10.1016/j.bbagen.2009.04.008
doi: 10.1016/j.bbagen.2009.04.008
pubmed: 19376194
pmcid: 2706308
Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J et al (2000) Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380(2):360–366. https://doi.org/10.1006/abbi.2000.1940
doi: 10.1006/abbi.2000.1940
pubmed: 10933892
Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE (2002) The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem 277(10):7849–7856. https://doi.org/10.1074/jbc.M110603200
doi: 10.1074/jbc.M110603200
pubmed: 11751867
Manetopoulos C, Hansson A, Karlsson J, Jonsson JI, Axelson H (2003) The LIM-only protein LMO4 modulates the transcriptional activity of HEN1. Biochem Biophys Res Commun 307(4):891–899. https://doi.org/10.1016/s0006-291x(03)01298-1
doi: 10.1016/s0006-291x(03)01298-1
pubmed: 12878195
Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R (2005) Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res 65(22):10594–10601. https://doi.org/10.1158/0008-5472.CAN-05-2268
doi: 10.1158/0008-5472.CAN-05-2268
pubmed: 16288053
Charitidi K, Meltser I, Tahera Y, Canlon B (2009) Functional responses of estrogen receptors in the male and female auditory system. Hear Res 252(1–2):71–78. https://doi.org/10.1016/j.heares.2008.12.009
doi: 10.1016/j.heares.2008.12.009
pubmed: 19450435
Yamamoto T, Matsuda T, Junicho A, Kishi H, Saatcioglu F, Muraguchi A (2000) Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett 486(2):143–148. https://doi.org/10.1016/s0014-5793(00)02296-1
doi: 10.1016/s0014-5793(00)02296-1
pubmed: 11113455
Garcia-Berrocal JR, Nevado J, Ramirez-Camacho R, Sanz R, Gonzalez-Garcia JA, Sanchez-Rodriguez C, Cantos B, Espana P et al (2007) The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol 152(7):1012–1020. https://doi.org/10.1038/sj.bjp.0707405
doi: 10.1038/sj.bjp.0707405
pubmed: 17906689
pmcid: 2095105